These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35746708)

  • 21. SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    Wang X; Wang W; Wang T; Wang J; Jiang Y; Wang X; Qiu Z; Feng N; Sun W; Li C; Yang S; Xia X; He H; Gao Y
    J Virol; 2023 Mar; 97(3):e0001123. PubMed ID: 36877072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemia.
    Ruan GJ; Wu X; Gwin KA; Manske MK; Abeykoon JP; Bhardwaj V; Witter TL; Schellenberg MJ; Rabe KG; Kay NE; Parikh SA; Witzig TE
    Haematologica; 2024 Sep; 109(9):2884-2892. PubMed ID: 38654668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses.
    Kohyama M; Suzuki T; Nakai W; Ono C; Matsuoka S; Iwatani K; Liu Y; Sakai Y; Nakagawa A; Tomii K; Ohmura K; Okada M; Matsuura Y; Ohshima S; Maeda Y; Okamoto T; Arase H
    Int Immunol; 2023 Jan; 35(1):43-52. PubMed ID: 36053553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ORF8 Protein of SARS-CoV-2 Modulates the Spike Protein and Its Implications in Viral Transmission.
    Chou JM; Tsai JL; Hung JN; Chen IH; Chen ST; Tsai MH
    Front Microbiol; 2022; 13():883597. PubMed ID: 35663899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of SARS-CoV-2 accessory proteins in immune evasion.
    Zandi M; Shafaati M; Kalantar-Neyestanaki D; Pourghadamyari H; Fani M; Soltani S; Kaleji H; Abbasi S
    Biomed Pharmacother; 2022 Dec; 156():113889. PubMed ID: 36265309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 ORF8 dimerization and binding mode analysis with class I MHC: computational approaches to identify COVID-19 inhibitors.
    Selvaraj C; Dinesh DC; Pedone EM; Alothaim AS; Vijayakumar R; Rudhra O; Singh SK
    Brief Funct Genomics; 2023 Apr; 22(2):227-240. PubMed ID: 36827221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.
    Zhang Y; Chen Y; Li Y; Huang F; Luo B; Yuan Y; Xia B; Ma X; Yang T; Yu F; Liu J; Liu B; Song Z; Chen J; Yan S; Wu L; Pan T; Zhang X; Li R; Huang W; He X; Xiao F; Zhang J; Zhang H
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34021074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    Ponde NO; Shoger KE; Khatun MS; Sarkar MK; Dey I; Taylor TC; Cisney RN; Arunkumar SP; Gudjonsson JE; Kolls JK; Gottschalk RA; Gaffen SL
    J Immunol; 2023 Jul; 211(2):252-260. PubMed ID: 37265402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 ORF8 accessory protein is a virulence factor.
    Bello-Perez M; Hurtado-Tamayo J; Mykytyn AZ; Lamers MM; Requena-Platek R; Schipper D; Muñoz-Santos D; Ripoll-Gómez J; Esteban A; Sánchez-Cordón PJ; Enjuanes L; Haagmans BL; Sola I
    mBio; 2023 Oct; 14(5):e0045123. PubMed ID: 37623322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.
    Su YCF; Anderson DE; Young BE; Linster M; Zhu F; Jayakumar J; Zhuang Y; Kalimuddin S; Low JGH; Tan CW; Chia WN; Mak TM; Octavia S; Chavatte JM; Lee RTC; Pada S; Tan SY; Sun L; Yan GZ; Maurer-Stroh S; Mendenhall IH; Leo YS; Lye DC; Wang LF; Smith GJD
    mBio; 2020 Jul; 11(4):. PubMed ID: 32694143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 29-nucleotide deletion in SARS-CoV: truncated versions of ORF8 are under purifying selection.
    Bykova A; Saura A; Glazko GV; Roche-Lima A; Yurchenko V; Rogozin IB
    BMC Genomics; 2023 Jul; 24(1):387. PubMed ID: 37430204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells.
    Hullsiek R; Li Y; Snyder KM; Wang S; Di D; Borgatti A; Lee C; Moore PF; Zhu C; Fattori C; Modiano JF; Wu J; Walcheck B
    Front Immunol; 2022; 13():841859. PubMed ID: 35281028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rescuing the Host Immune System by Targeting the Immune Evasion Complex ORF8-IRF3 in SARS-CoV-2 Infection with Natural Products Using Molecular Modeling Approaches.
    Albutti A
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.
    Rieke GJ; van Bremen K; Bischoff J; ToVinh M; Monin MB; Schlabe S; Raabe J; Kaiser KM; Finnemann C; Odainic A; Kudaliyanage A; Latz E; Strassburg CP; Boesecke C; Schmidt SV; Krämer B; Rockstroh JK; Nattermann J
    J Infect Dis; 2022 May; 225(10):1688-1693. PubMed ID: 35323975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.
    Hassan SS; Kodakandla V; Redwan EM; Lundstrom K; Pal Choudhury P; Abd El-Aziz TM; Takayama K; Kandimalla R; Lal A; Serrano-Aroca Á; Azad GK; Aljabali AAA; Palù G; Chauhan G; Adadi P; Tambuwala M; Brufsky AM; Baetas-da-Cruz W; Barh D; Azevedo V; Bazan NG; Andrade BS; Santana Silva RJ; Uversky VN
    PeerJ; 2022; 10():e13136. PubMed ID: 35341060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
    Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving.
    Beum PV; Lindorfer MA; Taylor RP
    J Immunol; 2008 Aug; 181(4):2916-24. PubMed ID: 18684983
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Takatsuka H; Fahmi M; Hamanishi K; Sakuratani T; Kubota Y; Ito M
    Front Med (Lausanne); 2022; 9():824622. PubMed ID: 35178414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 ORF8 reshapes the ER through forming mixed disulfides with ER oxidoreductases.
    Liu P; Wang X; Sun Y; Zhao H; Cheng F; Wang J; Yang F; Hu J; Zhang H; Wang CC; Wang L
    Redox Biol; 2022 Aug; 54():102388. PubMed ID: 35792438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.